SYNAGEVA BIOPHARMA CORP - COM (GEVA)

CUSIP: 87159A103

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / COM
Total 13F shares
35,360,562
Share change
+1,880,990
Total reported value
$2,432,115,004
Put/Call ratio
208%
Price per share
$68.78
Number of holders
117
Value change
+$108,259,962
Number of buys
60
Number of sells
60

Quarterly Holders Quick Answers

What is CUSIP 87159A103?
CUSIP 87159A103 identifies GEVA - SYNAGEVA BIOPHARMA CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SYNAGEVA BIOPHARMA CORP - COM (GEVA) as of Q3 2014

As of 30 Sep 2014, SYNAGEVA BIOPHARMA CORP - COM (GEVA) was held by 117 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,360,562 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, Capital Research Global Investors, COLUMBIA WANGER ASSET MANAGEMENT LLC, FMR LLC, VANGUARD GROUP INC, BB Biotech AG, Capital World Investors, BlackRock Fund Advisors, JANUS CAPITAL MANAGEMENT LLC, and Sectoral Asset Management Inc. This page lists 117 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.